Filings in a case against Bayer and Johnson & Johnson over the blood-thinning drug Xarelto said the companies helped mislead editors at The New England Journal of Medicine.
from NYT > Health http://ift.tt/1Y1q5vk
via health&fitness
Aucun commentaire:
Enregistrer un commentaire